Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Novella Clinical (Novella) and OSI Pharmaceuticals (OSI) are going to expand their existing clinical service agreement. As per the new deal, effective February 1, 2010, Novella will provide clinical research and related services to OSI for a period of two years, as OSI transitions its clinical operations to its new Ardsley, New York campus.
Subscribe to our email newsletter
Reportedly, Novella will assume the use of some of OSI’s facilities in Boulder and employ members of OSI’s Boulder staff.
OSI had previously announced plans to consolidate its US operations onto a single campus located in Ardsley, New York. OSI has begun consolidation of approximately 350 current US employees from its facilities in Melville and Farmingdale, New York, Boulder, Colorada, and Cedar Knolls, New Jersey.
Colin Goddard, CEO of OSI, said: “This is a win-win agreement between OSI and Novella and for the OSI Boulder employees who have chosen not to relocate with the company. As we execute our plan to capture the full strategic value of our oncology franchise and to simplify our business by bringing all our US employees onto one campus, the expanded agreement will provide continuity of clinical operations, biostatistics, medical writing and regulatory affairs for certain ongoing clinical studies as the company transitions functions to its new campus in Ardsley, New York.”